000 | 01893 a2200589 4500 | ||
---|---|---|---|
005 | 20250517191638.0 | ||
264 | 0 | _c20180814 | |
008 | 201808s 0 0 eng d | ||
022 | _a1600-0609 | ||
024 | 7 |
_a10.1111/ejh.13013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKalnoky, Michael | |
245 | 0 | 0 |
_aCytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression. _h[electronic resource] |
260 |
_bEuropean journal of haematology _cMar 2018 |
||
300 |
_a294-303 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aBlack or African American |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAntimalarials _xadverse effects |
650 | 0 | 4 | _aAsian People |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aContraindications, Drug |
650 | 0 | 4 |
_aErythrocytes _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFlow Cytometry _xmethods |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aGlucosephosphate Dehydrogenase _xgenetics |
650 | 0 | 4 |
_aGlucosephosphate Dehydrogenase Deficiency _xenzymology |
650 | 0 | 4 | _aHemizygote |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMosaicism |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPrimaquine _xadverse effects |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aSoftware |
650 | 0 | 4 | _aThailand |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aBancone, Germana | |
700 | 1 | _aKahn, Maria | |
700 | 1 | _aChu, Cindy S | |
700 | 1 | _aChowwiwat, Nongnud | |
700 | 1 | _aWilaisrisak, Pornpimon | |
700 | 1 | _aPal, Sampa | |
700 | 1 | _aLaRue, Nicole | |
700 | 1 | _aLeader, Brandon | |
700 | 1 | _aNosten, Francois | |
700 | 1 | _aDomingo, Gonzalo J | |
773 | 0 |
_tEuropean journal of haematology _gvol. 100 _gno. 3 _gp. 294-303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ejh.13013 _zAvailable from publisher's website |
999 |
_c27888643 _d27888643 |